首页> 外国专利> A DEPROTEINISED CALF BLOOD PREPARATION FOR USE IN PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL POLYNEUROPATHY

A DEPROTEINISED CALF BLOOD PREPARATION FOR USE IN PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL POLYNEUROPATHY

机译:一种无蛋白的小腿血液制剂,用于预防或治疗糖尿病性周围神经病变

摘要

The present invention relates to a deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy, wherein the deproteinised calf blood preparation is administered parenterally at least once and wherein the parenteral administration is followed by a period of enteral administration. Preferably, 20 doses of deproteinised calf blood preparation is administered intravenously once daily for a period of 20-36 days followed by an oral administration of the deproteinised calf blood preparation for 140 days. In a preferred embodiment of the present invention, the deproteinised calf blood preparation is the medicament Actovegin®.
机译:本发明涉及用于预防或治疗糖尿病性周围多发性神经病的脱蛋白小牛血液制剂,其中所述脱蛋白小牛血液制剂至少肠胃外给药一次,其中肠胃外给药之后是肠内给药。优选地,每天一次静脉内给予20剂脱蛋白的牛犊血制剂,持续20-36天,随后口服脱蛋白的牛犊血制剂140天。在本发明的一个优选实施方案中,脱蛋白的小牛血液制剂是药物Actovegin®。

著录项

  • 公开/公告号EP2340026B1

    专利类型

  • 公开/公告日2017-12-06

    原文格式PDF

  • 申请/专利权人 TAKEDA AUSTRIA GMBH;

    申请/专利号EP20090815639

  • 发明设计人 MOVSESYAN LUSINE;

    申请日2009-09-29

  • 分类号A61K35/14;A61P3/10;A61P25/02;

  • 国家 EP

  • 入库时间 2022-08-21 13:18:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号